Merck and Vioxx

Good Essays
Unit #1 – Ethics 1) Introduction of Vioxx a) Introduction in 1999 b) Withdrawal of the drug in 2004 due to heart attacks c) Merck’s knowledge of the effects of Vioxx and unethical decision to continue to sell the drug 2) Vigor Study d) Vioxx lessened stomach bleeding e) Results also showed higher risk of heart attacks f) Merck blamed naproxen for skewing the results against Vioxx 3) New England Journal of Medicine Omission g) Merck omits three heart attacks from article submission h) Inclusion of omitted data caused a significantly greater result 4) FDA Reaction i) Letter regarding downplay of risks j) Addition of warning label to Vioxx k) Additional study results 5) Approve Study l) Results with placebo group cause Merck to recall drug 6) Trials m) Challenge of showing causation n) 18 month defense 7) Settlement o) $4.85 Billion Settlement p) Admission of guilt 8) Merck’s Choices q) Merck made choices that showed clear wrongdoing

Introduction of Vioxx
In May of 1999, the FDA approved the use of rofecoxib. Marketed under the name of Vioxx, rofecoxib was manufactured and distributed by Merck, a large pharmaceutical company. Doctors prescribed the drug as a non-steroidal anti-inflammatory and prescription painkiller. Five years after its release, rofecoxib was withdrawn because of a study that showed the drug more than doubled the risk of heart attack or stroke. Because of Merck’s ongoing and increasing knowledge of the dangerous effects of the drug while continuing to distribute rofecoxib, Merck should be held accountable for acting unethically.
Vigor Study
Less than a year after the drug’s release, a study named Vigor was completed. The study’s intent was to compare Vioxx and naproxen and the drugs’ effects on the gastrointestinal system. Results from the study showed Vioxx lessened internal bleeding but the

You May Also Find These Documents Helpful

  • Better Essays

    Merck and Vioxx

    • 944 Words
    • 4 Pages

    6, page 358 5 References 6 Assignment 3 – Class 3 # 4, page 313 – Merck & Vioxx According to The New York Times article, “Merck to Pay $950 Million Over Vioxx” by Duff Wilson, the following lawsuits have been settled by Merck: Merck has agreed to pay $950 million and has pleaded guilty to a criminal charge over the marketing and sales of the painkiller Vioxx, the company and the Justice Department said Tuesday. Merck agreed to pay a $321 million criminal fine and plead guilty to one misdemeanor…

    • 944 Words
    • 4 Pages
    Better Essays
  • Better Essays

    Merck and Vioxx Analysis

    • 1612 Words
    • 7 Pages

    Business and Professional Ethics MERCK AND THE MARKETING OF VIOXX – CASE ANALYSIS Questions 1) What are the highlights of the case? 2) What are the ethical issues in the case? 3) What the ethical theories evidenced in the case? 4) How would you resolve the problem? What are the ethical issues in the case? In identifying the issue(s) we first have to identify the level in which this business is operating. Merck & Company was a top, well respected pharmaceutical company in America…

    • 1612 Words
    • 7 Pages
    Better Essays
  • Good Essays

    Merck Vioxx Paper

    • 710 Words
    • 3 Pages

    In the year 2000, Merck produced a controversial product called Vioxx. Four years later it gained worldwide attention because of the drug’s potential cardiovascular risks. This was detrimental to the company’s reputation because it was alleged Merck knowingly distributed Vioxx despite its risk. Both Barbara Martinez and Anne W. Mathews of the Wall Street Journal wrote articles into the investigation of Vioxx. Their article suggests Merck knew the dangers of Vioxx at an early stage of its clinical…

    • 710 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Merck Vioxx Recall

    • 1169 Words
    • 5 Pages

    Merck, the FDA, and the VIOXX Recall MBA 520-D4C2 Ethics & Leadership in a Global Environment April 22, 2012 Merck and Vioxx Recall Did Merck act in social and ethical manner? In 2005, Merck was ranked fourth in sales among pharmaceutical companies. Merck had released the drug Vioxx, for treating Osteoarthritis in late 1990. Merck as a company has a reputation of being one of the most ethical and…

    • 1169 Words
    • 5 Pages
    Good Essays
  • Good Essays

    MAN 4720 Nov. 15, 2011 Merck, the FDA, and the Vioxx Recall In 1999 the Food and Drug Administration (FDA) had approved Vioxx, what would become Merck’s “blockbuster” drug. Although the FDA had approved the drug there was uncertainty of the safety of drug. Vioxx was approved to treat a variety of conditions, such as osteoarthritis and acute pain, but there was also a chance that it would increase cardiovascular problems. What I found most interesting about this case was the changes in how drugs…

    • 553 Words
    • 3 Pages
    Good Essays
  • Good Essays

    3rd, 2014 Case 5: Merck, the FDA, and the Vioxx Recall Section I Merck was one of the world’s leading pharmaceutical firms. The company ranked 4th I sales after Pfizer and Johnson & Johnson and it ranked 5th in assets and market value. Merck ranked 1st in profits, earning $7.33 billion on $30.78 billion in sales. In 2006, Merck faced major challenges with their once best selling prescription painkillers, Vioxx which was pulled off the market in September of 2004 after Merck learned it increased…

    • 2172 Words
    • 7 Pages
    Good Essays
  • Good Essays

    Merck, the FDA, and the VIOXX Recall MBA 520 Ethics and Leadership in a Global Environment 11.15.2009 MBA 520 15 November 2009 Merck, the FDA, and the VIOXX Recall In 1999, Merck started a clinical trial called VIGOR, checking the effectiveness of VIOXX in patients with gastrointestinal problems, and in this trial they noted for the first time that patients taking VIOXX suffered roughly twice as many heart attacks and strokes as those taking the control, Naproxen.…

    • 672 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Merck, the FDA, and the Vioxx Recall 1. Do you believe that Merck acted in a socially responsible and ethical manner with regard to Vioxx? Why or Why not? In your answer, please address the company’s drug development and testing, marketing and advertising, relationships with government regulators and policymakers, and handling of the recall. I do not believe that Merck made a socially responsible decision when Vioxx was introduced into the pharmaceutical market. Scientists that were involved…

    • 713 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Running head: CASE STUDY: MERCK & COMPANY: THE VIOXX RECALL Merck & Company: The Vioxx Recall Albert Balogun California Baptist University BUS 520A: Managerial Ethics Jim Bishop, PhD June 30, 2010 Merck & Company: The Vioxx Recall The issues involved in Merck, a pharmaceutical manufacturing company’s recall of one its products, Vioxx, is the effect of direct-to-consumer (DTC) advertising of prescription drug on the society public…

    • 2006 Words
    • 9 Pages
    Powerful Essays
  • Satisfactory Essays

    Merck, Vioxx and the FDA Recall, case no. 6 1. I believe that Merck was completely responsible for everything that came along with releasing Vioxx to the public. The signs that the drug might not be as safe as they had hoped for should have been enough for them to halt on the release. It was unethical thing they did was not do all the research to find out how serious the effects of the drug really were. 2. Merck should have run more tests and found out the severity of the symptoms, and seen…

    • 318 Words
    • 2 Pages
    Satisfactory Essays